AbhishekTripathiMD

PubMed

• Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.
  Joseph J Park, Alec Chu, Jinju Li, Alicia Ali, Rana R McKay, Clara Hwang, Matthew K Labriola, Albert Jang, Deepak Kilari, George Mo, Deepak Ravindranathan, Laura S Gra...> ;JCO Precision Oncology. 2024 Apr 1
• Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.
  Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez, David D Yang, Abhishek Tripathi, Jacqueline M Kilar, Meredith Flynn, Brianna May...> ;Cancer Immunology Research. 2024 Mar 29
• 1 citations
  Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.
  Castro, D., Prajapati, S., Feng, M., Chan, E., Lee, K., Paul, T., Sehgal, I., Patel, J., Li, X., Zengin, Z., Ebrahimi, H., Govindarajan, A., Meza, L., Mercier, B., Cha...> ;BJU International. 2024 Mar 1
• Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer and Response to Checkpoint Inhibition.
  Zang, P., Barragan-Carrillo, R., Chehrazi-Raffle, A., Chawla, N., Tripathi, A., Pal, S., Dorff, T.> ;JAMA Oncology. 2024 Feb 8
• Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends o...
  Hedyeh Ebrahimi, Daniela V Castro, Matthew I Feng, Sweta R Prajapati, Kyle O Lee, Elyse H Chan, Trishita Paul, Ishaan Sehgal, Jalen Patel, Xiaochan Li, Zeynep B Zengin...> ;Clinical Genitourinary Cancer. 2023 Dec 1
• Racial and ethnic differences in perceptions of germline or somatic DNA sequencing among patients with advanced prostate, urothelial, or kidney cancer.
  Cristiane Decat Bergerot, Errol J Philip, Jasnoor Malhotra, Paulo Gustavo Bergerot, Daniela V Castro, Ameish Govindarajan, Sabrina Salgia, Meghan Salgia, Nicholas Salg...> ;Journal of Genetic Counseling. 2023 Sep 12
• Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis.
  Meza, L., Zengin, Z., Salgia, S., Malhotra, J., Karczewska, E., Dorff, T., Tripathi, A., Ely, J., Kelley, E., Mead, H., Hsu, J., Dizman, N., Salgia, N., Chawla, N., Ch...> ;The Oncologist. 2023 Sep 7
• FGFR Inhibition: Understanding and Overcoming Resistance.
  Abhishek Tripathi, Daneng Li, Sumanta K Pal> ;Cancer Discovery. 2023 Sep 6
• Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer.
  Park, J., Holland, B., Jang, A., Clara Hwang, Nicholas C Henderson, Shih-Chun Chu, Brandon Holland, Frank C Cackowski, Amanda Pilling, Albert Jang, Shoshana Rothstein,...> ;JAMA Network Open. 2023 Sep 5
• Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration.
  Tanya Dorff, Zeynep Zengin, Nicholas Henderson, Alicia Ali, Charles Nguyen, Clara Hwang, Pedro C Barata, Mehmet Bilen, Laura Graham, George Mo, Deepak Kilari, Abhishek...> ;Research Square. 2023 Aug 10
• 1 citations
  Poly (ADP-ribose) Polymerase Inhibition in Advanced Urothelial Carcinoma.
  Abhishek Tripathi, Seth P Lerner> ;JCO Precision Oncology. 2023 Aug 1
• Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study.
  Cristiane Decat Bergerot, Errol J Philip, Ameish Govindarajan, Daniela Castro, Jasnoor Malhotra, Paulo Bergerot, Sabrina Salgia, Meghan Salgia, Nicholas Salgia, JoAnn ...> ;Clinical Genitourinary Cancer. 2023 Dec 1
• Incorporating Prognostic Models Into Clinical Practice for Patients With Castration-Resistant Prostate Cancer.
  Tanya Dorff, Abhishek Tripathi> ;Journal of Clinical Oncology. 2023 May 20
• 3 citations
  Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
  Nicolas Sayegh, Nishita Tripathi, Ameish Govindarajan, Zeynep B Zengin, Errol J Phillip, Luis Meza, Ramya Muddasani, Alexander Chehrazi-Raffle, Jasnoor Malhotra, JoAnn...> ;Clinical Genitourinary Cancer. 2023 Feb 1
• 2 citations
  Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.
  Hoskins, E., Samorodnitsky, E., Wing, M., Reeser, J., Hopkins, J., Murugesan, K., Kuang, Z., Vella, R., Stein, L., Risch, Z., Yu, L., Adebola, S., Paruchuri, A., Carpt...> ;JCO Precision Oncology. 2023 Jan 1
• Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
  Govindarajan, A., Salgia, N., Li, H., Castro, D., Mirzapoiazova, T., Armstrong, B., Zhao, D., Mercier, B., Dizman, N., Chawla, N., Zengin, Z., Meza, L., Tripathi, N., ...> ;Frontiers in Immunology. 2023 Jan 1
• 4 citations
  Therapeutic Landscape Beyond Immunotherapy in Advanced Urothelial Carcinoma: Moving Past the Checkpoint.
  Abhishek Tripathi, Guru P Sonpavde, MacDougall, K.> ;Drugs. 2022 Nov 1
• 6 citations
  Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
  Rafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos, Scott Dawsey, Shilpa Gupta, Lucia Carril-Ajuria, Daniel Castellano, Ivan de Kouchko...> ;Clinical Genitourinary Cancer. 2022 Dec 1
• 3 citations
  Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma.
  Nishita Tripathi, Yeonjung Jo, Abhishek Tripathi, Nicolas Sayegh, Haoran Li, Roberto Nussenzveig, Benjamin Haaland, Vinay M Thomas, Sumati Gupta, Benjamin L Maughan, U...> ;Urologic Oncology. 2022 Nov 1
• 2 citations
  Patient-Reported Outcomes in Early Phase Clinical Trials: An Opportunity to Actively Promote Patient-Centered Care.
  Cristiane Decat Bergerot, Sumanta K Pal, Abhishek Tripathi> ;The Oncologist. 2022 Sep 2
• 8 citations
  Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
  Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos, Scott Dawsey, Shilpa Gupta, Lucia Carril-Ajuria, Daniel Castellano, Ivan de Kouchko...> ;Clinical Genitourinary Cancer. 2022 Oct 1
• 3 citations
  Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
  Rafee Talukder, Dimitrios Makrakis, Leonidas N Diamantopoulos, Lucia Carril-Ajuria, Daniel Castellano, Ivan De Kouchkovsky, Vadim S Koshkin, Joseph J Park, Ajjai Alva,...> ;Clinical Genitourinary Cancer. 2022 Apr 1
• 3 citations
  Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
  Dimitrios Makrakis, Rafee Talukder, Leonidas Nikolaos Diamantopoulos, Lucia Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Vadim S. Koshkin, Joseph J. Park, Aj...> ;BJU International. 2021 Oct 25
• 14 citations
  PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer.
  Vadim S. Koshkin, Vaibhav G. Patel, Alicia Ali, Mehmet Asim Bilen, Deepak Ravindranathan, Joseph J. Park, Olesia Kellezi, Marcin Cieslik, Justin Shaya, Angelo Cabal, L...> ;Prostate Cancer and Prostatic Diseases. 2021 Aug 6
• 1 citations
  Nature versus Nurture: Investigating Racial Disparity in Advanced Prostate Cancer.
  Nishita Tripathi, Neeraj Agarwal, Abhishek Tripathi> ;The Oncologist. 2021 Nov 1
• Join now to see all

Lectures

• Prognostic significance of CD73 expression in localized renal cell carcinoma (RCC). 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
• NT5E expression and the immune landscape of prostate cancer (PC): An analysis from The Cancer Genome Atlas database. 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019